YDES
YD Bio Limited Ordinary Shares NASDAQ Listed Aug 29, 2025$2.98
Pre-mkt
$2.97
-0.37%
Mkt Cap $211.1M
52w Low $1.70
5.5% of range
52w High $25.00
50d MA $2.47
200d MA $7.28
P/E (TTM)
—
EV/EBITDA
—
P/B
1.9x
Debt/Equity
0.0x
ROE
—
P/FCF
-2.6x
RSI (14)
70.90
ATR (14)
$0.31
Beta
0.22
50d MA
$2.47
200d MA
$7.28
Avg Volume
217.6K
Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.
No. 3, Xingnan St. · Taipei, TX 115001 · TW
Data updated apr 24, 2026 11:46am
· Source: financialmodelingprep.com